ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS

• Better Data, Better Decisions

  Learn how to achieve greater certainty in clinical trial financial management by leveraging adaptive, accurate, and defendable fair market value.

• The Power Of A Collaboration Platform

  Using a recent Phase III Endocrinology trial as a primary case study, this article illustrates the qualitative shift from administrative burden to strategic oversight.

• Scaling Global Vaccine Mega-Trials For A Top Five Pharma

  See how high-volume enrollment, dynamic safety data capture, and rapid iteration can support global studies operating under intense timelines and scale.

• The Strategic Case For RTSM in Phase 1 Trials

  Phase 1 trials demand precision and speed. RTSM delivers real-time control over enrollment, dosing, and supply, reducing risk and enabling adaptive strategies that keep timelines on track.

• AI Maturity In Clinical Development

  The future of clinical research relies on operationalizing AI in a scalable, sustainable manner, ensuring that both technological and human factors are harmonized in this transformative journey.

• A Guide To Medical Coding In Clinical Trials

  Medical coding transforms free-text clinical data into standardized terminology, enabling consistent analysis, safety monitoring, and regulatory review. Clear guidelines and quality control help reduce variability and protect data integrity across the entire clinical trial lifecycle.

• DTx Company Leverages Real-World Evidence Platform In Registry Study

  Discover how Castor’s eClinical system enabled a groundbreaking study in behavioral disorder treatment to collect Real-World Evidence (RWE) to support product research and claims.

• What The Joint FDA And EMA's AI Principles Can Mean For Clinical Trial Technology

  New FDA/EMA principles align global expectations for AI in drug trials, emphasizing transparency, human-centric design, and risk-based governance to ensure data integrity and patient safety.

• Patient-Centricity Is In Everything We Do: Designing Accessible eClinical Technology

  By prioritizing patient centricity within an eClinical platform’s design, sponsors can tailor patient engagement to achieve outcomes based on a study’s indication, patient population, and end goals.

• Cytokine Release Syndrome Monitoring

  Here we introduce an innovative risk-monitoring solution aimed at mitigating Cytokine Release Syndrome (CRS), a critical complication in immunotherapy that often leads to prolonged hospitalization.